<unk>  is a combination of an angiotensin converting enzyme inhibitor and a dihydropyridine calcium channel blocker that is FDA approved for the treatment of hypertension to lower blood pressure in patients not adequately controlled with monotherapy, or as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include headache, cough, peripheral edema, and pulmonary edema.
Perindopril arginine, amlodipine besylate
Enalapril\Hydrochlorothiazide
Amlodipine besylate and Atorvastatin calcium trihydrate
Amlodipine besylate and Olmesartan medoxomil
Olmesartan Medoxomil-Hydrochlorothiazide
Losartan potassium and Hydrochlorothiazide
Metoprolol succinate/Hydrochlorothiazide
Amlodipine besylate and Valsartan